Home > Insider Trading > Filing (0000310764-23-000001)

Filing Details

Accession Number:: 0000310764-23-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-11 19:02:51
Reporting Period:: 2023-01-09

Accepted Time:: 2023-01-11 19:02:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310764	Stryker Corp	SYK	Surgical & Medical Instruments & Apparatus (3841)	381239739

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1663095	Kathryn M Fink	2825 Airview Blvd Kalamazoo MI 49002	Vp, Chief Hr Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-01-09	3,536	$260.00	9,264	No	4	S	Direct
Common Stock	Acquisiton	2023-01-10	1,397	$93.06	10,661	No	4	M	Direct
Common Stock	Acquisiton	2023-01-10	5,174	$96.64	15,835	No	4	M	Direct
Common Stock	Disposition	2023-01-11	1,158	$256.49	14,677	No	4	S	Direct
Common Stock	Disposition	2023-01-11	3,417	$257.30	11,260	No	4	S	Direct
Common Stock	Disposition	2023-01-11	1,403	$258.45	9,857	No	4	S	Direct
Common Stock	Disposition	2023-01-11	346	$259.49	9,511	No	4	S	Direct
Common Stock	Disposition	2023-01-11	116	$261.12	9,395	No	4	S	Direct
Common Stock	Disposition	2023-01-11	131	$262.72	9,264	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option granted 02/11/2015 (right to buy)	Disposition	2023-01-10	1,397	$0.00	1,397	$93.06
Common Stock	Employee Stock Option granted 02/10/2016 (right to buy)	Disposition	2023-01-10	5,174	$0.00	5,174	$96.64

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-02-10	No	4	M	Direct
0		2026-02-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	342	Indirect	By 401K

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2022.
Includes 26 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2022, the date of the latest available statement of the reporting person's ESPP holdings.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $255.81 to $256.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $256.85 to $257.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $257.855 to $258.82, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $259.105 to $259.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $260.46 to $261.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $262.67 to $263, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.